Loading...
Loading...
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.
Sub potent drug: during the 9-month stability test conducted, the assay value for the affected lot was below specification limit.